SUN PHARMA

We are pleased to announce that the primary results of the Phase III PIVOTAL trial of a biopharmaceutical product, Nidlegy will be presented at the American Society of Clinical Oncology (ASCO) 2024. Sun Pharma entered into a distribution, license and supply agreement with Philogen in 2023 for commercialising Nidlegy in Europe, Australia and New Zealand for the treatment of skin cancers. Read more here: http://bit.ly/4aNiVFA

Read more about Sun’s strategic plans for expanding its specialty business in this article in The Economic Times. As a global pharmaceutical company, we continue to enhance our focus on innovation to introduce medicines that address various unmet needs of patients. This pursuit of innovation not only positions us favourably for growth, but also showcases our commitment to better patient care. #WeAreSun #SpecialtyBusiness #MediaCoverage

In a recent interaction with The Economic Times our North America CEO, Abhay Gandhi shares insights on our global specialty business crossing the US$ 1 billion milestone in FY24, prospective launch of our innovative drug, Deuruxolitnib and much more. #SpecialtyBusiness #MediaCoverage #Q4Results #YearEndResults #WeAreSun

The merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders (including a vote of the majority of shares held by Taro shareholders unaffiliated with Sun Pharma) at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024. Read more here: https://lnkd.in/grNj3-Yr #WeAreSun #SunPharma

Our Chairman and Managing Director, Dilip Shanghvi, provides an overview of our Q4 and full year results for FY24. Read more: http://bit.ly/3UUx7XC #Q4Results #FullYearResults #SunPharma

We have announced our Q4 and full year results for FY24. Read more: http://bit.ly/3UUx7XC #ReachingPeopleTouchingLives #Q4Results #FullYearResults #SunPharma

Today on International Clinical Trials Day, we celebrate the incredible role played by clinical research in advancing healthcare, made possible by the invaluable contribution of patients, researchers and healthcare professionals. #ReachingPeopleTouchingLives #InternationalClinicalTrialsDay

We hosted a global painting competition for the incredibly talented children of our employees, sparking their creativity to new heights! Here's a look at the winning entries, carefully selected by the judge Swati Ranka, encapsulating Sun's 40th anniversary theme, 'Together We Shine Brightest'. #WeareSun #40UnderTheSun

Our Vice President - MR, SFE & Digital, India Business, Vivek Khanvilkar, reflects on his decade long journey with Sun. The driving force behind his steadfast commitment to the organisation is our culture of trust, empowerment and growth, stemming from Sun's inherent values of humility, integrity, passion, and innovation. #40UnderTheSun #WeAreSun #SunPharma #LeadershipJourney

Our Regional Excellence Awards for Western Europe and Australia & New Zealand celebrated team members who went the extra mile to positively impact the organization and role modelled the values core to Sun. We congratulate our exceptional colleagues who emerged as winners this year! #WeAreSun Monisha Chadha GRP® Nanditha U. Mitaalee Vinay Sawant Milagros Daniza Chong Caroline Thomas Anish Sharma Laura Howard Eleonora Fossati Cornelia Moopanar Ariam Eunice Rivera JYOTI BORKHATARIA Binal Patel